Publications
Export 26 results:
Filters: Author is Marie-France Demers [Clear All Filters]
, “A Chart Audit Study of Clozapine Utilization in Early Psychosis.”, J Clin Psychopharmacol, vol. 41, no. 3, pp. 275-280, 2021.
, “Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.”, J Psychopharmacol, vol. 35, no. 9, pp. 1152-1157, 2021.
, “Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program.”, CNS Drugs, vol. 35, no. 4, pp. 461-468, 2021.
, “Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychotics.”, World J Biol Psychiatry, pp. 1-8, 2020.
, “Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients: A Series of 6 Case Reports.”, J Clin Psychopharmacol, vol. 40, no. 2, pp. 191-194, 2020.
, “"Real world" clinical effectiveness of paliperidone palmitate 3-monthly injectable in early psychosis patients.”, Psychopharmacology (Berl), 2020.
, “Case Reports of Aripiprazole and Problematic Gambling in Schizophrenia: A Critical Review of the Evidence.”, J Clin Psychopharmacol, vol. 39, no. 4, pp. 393-397, 2019.
, “Continuing clozapine despite recurrent neutropenia: A 8 year follow-up case report with granulocyte-colony stimulating factor as-required use.”, Asian J Psychiatr, 2018.
, “More intensive probing increases the detection of social anxiety disorders in schizophrenia.”, Psychiatry Res, vol. 268, pp. 358-360, 2018.
, “Social anxiety disorder in schizophrenia: a neglected, yet potentially important comorbidity.”, J Psychiatry Neurosci, vol. 43, no. 4, pp. 287-288, 2018.
, “[Initiating an antipsychotic drug treatment for schizophrenia: the situation in Quebec, Canada, from 1998 to 2006].”, Sante Ment Que, vol. 42, no. 1, pp. 85-103, 2017.
, “One year mirror-image study using paliperidone palmitate for relapse prevention of schizophrenia in four university hospitals in Canada.”, Schizophr Res, vol. 185, pp. 96-100, 2017.
, “Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study.”, Acta Psychiatr Scand, vol. 134, no. 5, pp. 374-384, 2016.
, “Comorbidity between anxiety disorders and recent-onset psychotic disorders.”, Schizophr Res, vol. 166, no. 1-3, pp. 353-4, 2015.
, “Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.”, Am J Drug Alcohol Abuse, vol. 34, no. 1, pp. 75-82, 2008.
, “Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy.”, J Psychopharmacol, vol. 22, no. 3, pp. 262-9, 2008.
, “[Improving detection and treatment of early psychosis in Québec: the Quebec association of early psychosis (l'Association québécoise des programmes pour premiers épisodes psychotiques, AQPPEP), sees to it].”, Sante Ment Que, vol. 32, no. 1, pp. 299-315, 2007.
, “Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.”, Curr Med Res Opin, vol. 22, no. 7, pp. 1277-85, 2006.
, “Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics.”, J Clin Psychiatry, vol. 65, no. 4, pp. 557-64, 2004.
, “First person account: Susan's cello.”, Schizophr Bull, vol. 28, no. 1, pp. 187-9, 2002.
, “Atypical antipsychotics and cardiovascular risk in schizophrenic patients.”, J Clin Psychopharmacol, vol. 21, no. 1, pp. 110-1, 2001.
, “[Psychosis and addiction: the experience of the Polyclinique Sainte-Anne.].”, Sante Ment Que, vol. 26, no. 2, pp. 62-91, 2001.
, “Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia. The Quebec Schizophrenia Study Group.”, J Clin Psychopharmacol, vol. 20, no. 3, pp. 295-304, 2000.
, “[Schizophrenia and psychoactive drug abuse: dual diagnostic problem].”, Can J Psychiatry, vol. 45, no. 6, pp. 572-3, 2000.
, “Visual and auditory hallucinations with the association of bupropion and valproate.”, Can J Psychiatry, vol. 45, no. 2, pp. 198-9, 2000.
